| PDF (637kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-217386
- DOI to cite this document:
- 10.5283/epub.21738
Alternative links to fulltext:Pubmed
Abstract
A prospective, randomized, double-blind study was performed in 40 patients (ASA class I-III) treated with atracurium to ascertain whether histamine release caused hemodynamic or cutaneous changes. The treated group of 20 patients was premedicated with the H1 antagonist dimetindene (0.2 mg/kg) and the H2 antagonist ranitidine (1.25 mg/kg); the control group of 20 patients received saline. Six ...

Owner only: item control page